Scholars Central

Research articlePublished 5 Oct 2023

Safety and Efficacy of Zynrelef® in Combination with a Single Unilateral or Bilateral Nerve Block Performed Prior to Surgery

Authors: Shiv Goel, Charles Luke, Matthew Holtzman, Benjamin Davies, Michael O’Malley, Dani Lavage, Carley Siedlecki, Jacques E Chelly

1Department of Anesthesiology and Perioperative Medicine, University of Pittsburgh Medical Center, Pennsylvania, USA; 2Department of Surgery, UPMC Shadyside Hospital, Pennsylvania, USA; 3Department of Urology, UPMC Shadyside Hospital, Pennsylvania, USA; 4Department of Orthopedic Surgery, UPMC Shadyside Hospital, Pennsylvania, USA

Journal of Pain & Relief

Volume 12 · Pages 1–5

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Purpose: The FDA recently approved Zynrelef® (A viscous solution of extended release of bupivacaine and meloxicam) to be applied at closure and providing postoperative analgesia for 72 hrs. Although the FDA didn’t restrict the use of nerve blocks in combination with this formulation, the safety and efficacy of such a combination has yet to be documented. This quality improvement study investigated this combination within the FDA-approved indications. Methods: Selected surgeons at two hospitals were chosen to use Zynrelef®. According to the standard of care, surgeons were also allowed to request single nerve blocks before surgery. The type of nerve blocks (unilateral or bilateral) performed included quadratus lumborum and paravertebral blocks for abdominal surgery, and adductor canal block for total knee replacement. Each block was performed with 20 mL of 0.375% bupivacaine (n=129) or 0.5% of ropivacaine (n=30). Pain scores, opioid consumption, and prescription refill requests at discharge were recorded. Patients discharged on the same day of surgery were separated into two groups-those who received single nerve blocks plus an Zynrelef® (group 1) vs. those receiving Zynrelef® only (group 2) and was analyzed using an un-paired t-test. Results: A total of 184 patients received Zynrelef®, including 25 patients who didn’t receive blocks, 44 who received unilateral blocks and 114 who received bilateral blocks. No symptoms suggestive of Local Anesthetic Toxicity (LAST) were observed. The use of the combination was associated with a 50% reduction in the number of patients filling their opioid prescription. Conclusion: This study provides evidence that the combination of a single unilateral or bilateral nerve block with Zynrelef® is safe.

Subjects

Surgery

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Pain & Relief.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Pain & Relief
  • SubjectSurgery
  • BylineArticles whose byline prints “Shiv Goel”
  • BylineArticles whose byline prints “Charles Luke”
  • BylineArticles whose byline prints “Matthew Holtzman”
  • BylineArticles whose byline prints “Benjamin Davies”
  • BylineArticles whose byline prints “Michael O’Malley”
  • BylineArticles whose byline prints “Dani Lavage”
  • BylineArticles whose byline prints “Carley Siedlecki”
  • BylineArticles whose byline prints “Jacques E Chelly”